Further, supplementation of peroxisome proliferator-activated receptor (PPAR)-γ pioglitazone was shown to upregulate HSPA1 mRNA and protein levels in atrial tissue of a rat model of AF, which resulted in attenuation of fibrosis and morphological changes [60]. This evidence concerns the gene HSPA1A and atrial fibrillation.